A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)
Clinical trial NCT01656395 · TERMINATED
Trial details
- NCT number
- NCT01656395
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-23
- Primary completion
- 2014-06-10
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.